logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11779619 B1

PDFFull Text
Date of Patent:
Oct. 10, 2023

Filed:

Dec. 23, 2019

Oncolytic virus for expression of immune checkpoint modulators

Applicant:

Transgene SA, Illkirch Graffenstaden, FR;

Inventors:

Nathalie Silvestre, Ergersheim, FR;

Michel Geist, Brumath, FR;

Karola Rittner, Strasbourg, FR;

Jean-Baptiste Marchand, Obernai, FR;

Christine Thioudellet, Strasbourg, FR;

Assignee:

Transgene SA, Illkirch Graffenstaden, FR;

Attorneys:

Panitch Schwarze Belisario & Nadel LLP

Eric M. Dunston

Primary Examiner:

Anne Marie S Wehbe

Int. Cl.
CPC ...
A61K 35/768 (2015.01); C07K 16/28 (2006.01); C12N 15/863 (2006.01); A61K 9/00 (2006.01); C07K 14/535 (2006.01); A61K 39/00 (2006.01); A61K 35/763 (2015.01); A61K 35/761 (2015.01); A61K 47/02 (2006.01); A61K 9/08 (2006.01); C12N 7/00 (2006.01); C12N 9/10 (2006.01); C12N 9/80 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 9/0019 (2013.01); C07K 14/535 (2013.01); C07K 16/2818 (2013.01); C07K 16/2896 (2013.01); C12N 15/8636 (2013.01); C12Y 204/02009 (2013.01); A61K 9/08 (2013.01); A61K 35/761 (2013.01); A61K 35/763 (2013.01); A61K 47/02 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5256 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C12N 7/00 (2013.01); C12N 9/1077 (2013.01); C12N 9/80 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24132 (2013.01); C12N 2799/023 (2013.01); C12Y 305/01023 (2013.01);
Abstract

The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.

Find Patent Forward Citations

Silvestre, Nathalie. (2023). Oncolytic virus for expression of immune checkpoint modulators (U.S. Patent No. 11779619). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11779619

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…